@Fenng: Among the entrepreneurs accompanying Trump to China, the company least familiar to the public should be Illumina. Illumina is the most important company in the global gene sequencing field, holding a dominant market position. In 2025, China imposed an import ban on Illumina's gene sequencers. This visit is obviously hoping to lift the ban...
Summary
The article introduces Illumina, the global gene sequencing giant, accompanying Trump on his visit to China, attempting to lift China's import ban on its gene sequencers. It also points out that BGI (Huada Gene) had already laid out its independent technology route by acquiring Complete Genomics, changing the market landscape.
Similar Articles
@seclink: 1. Trump approves Nvidia chip sales to China, but Beijing is not buying - Core: Trump allowed Nvidia to sell high-end chips to China late last year, seemingly a win-win. However, Chinese companies (Alibaba, Tencent, ByteDance, JD.com) have obtained H200 purchase permits from the US Department of Commerce, but the US Trade Representative has made it clear that chip export controls are not within the scope of US-China negotiations. Nvidia...
Trump approved Nvidia's sale of high-end chips (H200) to China, but Chinese companies (Alibaba, Tencent, etc.) obtained purchase permits while the US Trade Representative explicitly stated that export controls are not part of negotiations. Nvidia has essentially ceded the Chinese AI chip market to Huawei. This marks the substantial impact of US chip embargoes on AI computing supply chains.
@_FORAB: Both China and the U.S. are tightening AI? Reuters reports that Chinese regulators have held meetings with several leading companies to discuss possibly restricting overseas access to China's most advanced AI models, including those not yet released. Participants include ByteDance, Alibaba, and Zhipu AI (developer of the GLM model). In addition, authorities may introduce new measures to limit which investors can invest in Chinese AI startups.
Reuters reports that Chinese regulators have met with leading companies including ByteDance, Alibaba, and Zhipu AI to discuss possibly restricting overseas access to China's most advanced AI models (including unreleased ones), and may introduce new measures to limit foreign investment in Chinese AI startups.
China releases powerful DNA-screening AI tool for free to help fight rare diseases
Chinese researchers at BGI-Research released OneGenome, an open-source AI system that interprets gene mutations for clinical diagnosis, outperforming general LLMs like DeepSeek-v4, to help shorten the diagnostic odyssey for rare disease patients.
@JTLonsdale: 1/ US biotech is in crisis, right before AI should be saving millions. China is stealing away our industry and has surp…
US biotech is in crisis as China surpasses the US in blockbuster pharma deals; the next FDA Commissioner must overhaul the agency and beat China to unleash cures.
@CaoChangqing: In the meeting between Trump and Xi Jinping, Trump did not make concessions on the Taiwan issue, and there was no betrayal of Taiwan as left-wing media and yellow-left had previously hyped. This can be seen from the latest Reuters report. The talks primarily focused on trade and economic issues. The U.S. concession was to allow 10 Chinese companies, including Alibaba, ByteDance, Tencent, and JD.com, to purchase Nvidia H200 chips; Lenovo and Foxconn among others…
Trump and Xi Jinping met. The U.S. allowed 10 Chinese companies such as Alibaba, ByteDance, Tencent, and JD.com to purchase Nvidia H200 chips. Taiwan was not mentioned. Musk, Cook, and Huang Renxun (Jensen Huang) gave positive comments on the meeting.